SSRIS versus tricyclic antidepressants in depressed inpatients: A meta- analysis of efficacy and tolerability

Depression and Anxiety

Volumn 7, Issue SUPPL. 1, 1998, Pages 11-17

  Anderson, I M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Depression; Meta analysis; SSRIs; TCAs

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; NORADRENALIN; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; HAMILTON SCALE; HUMAN; META ANALYSIS; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; HUMANS; NOREPINEPHRINE; RANDOMIZED CONTROLLED TRIALS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0031960136     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I     Document Type: Article

References (40)

1. Altamura AC, Percudani M, Guercetti G, Invernizzi G (1989) Efficacy and tolerability of fluoxetine in the elderly: A double-blind study versus amitriptyline. Int Clin Psychopharmacol 4:103-106.
2. Amore M, Bellini M, Berardi D, Berlinzani L, Cervino G, Cremonini A, Ferrari G, Innamorati A (1989) Double-blind comparison of fluvoxamine and imipramine in depressed patients. Curr Ther Res 46:815-820.
3. Anderson LM, Tomenson BM (1994) The efficacy of selective serotonin reuptake inhibitors in depression. A meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 8:238-249.
4. Anderson IM, Tomenson BM (1995) Treatment discontinuation with selective serotonin reuptake inhibitors compared to tricyclic antidepressants: A meta-analysis. BMJ 310: 1433-1438.
5. Arminen S-L, Ikonen U, Pulkkinen M, Leinonen E, Mahlanen A, Koponen H, Kourula K, Ryyppo J, Lehtonen M-L, Vartiainen H, Lehtinen V, Tamminen T (1992) Paroxetine and imipramine: A 12 week, double-blind multicentre study in hospitalized depressed patients. Nord J Psychiatry 46(Suppl. 27): 27-31.
6. Byrne MM (1989) Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients. Acta Psychiatr Scand 80:138-139.
7. Danish University Antidepressant Group (1986) Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 90:131-138.
8. Danish University Antidepressant Group (1990) Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicentre study. J Affect Dis 18:289-299.
9. de Jonghe F, Ravelli DP, Tuynman-Qua H (1991) A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression. Pharmacopsychiatry 24:62-67.
10. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Contr Clin Trial 7:177-188.
11. De Wilde JEM, Doogan DP (1982) Fluvoxamine and chlorimipramine in endogenous depression. J Affect Dis 4:249-259.
12. Dick P, Ferrero E (1983) A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine. Br J Clin Pharmacol 15: 419S-425S.
13. Feighner P, Boyer WF, Meredith CH, Hendrickson GG (1989) A placebo-controlled in-patient comparison of fluvoxamine maleate and imipramine in major depression. Int Clin Psychopharmacol 4:239-244.
14. Gardner MJ, Altman DG (1989) Statistics with confidence. Brit Med J: Lond.
15. Gasperini M, Gatti F, Bellini L, Anniverno R, Smeraldi E (1992) Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine: A double-blind study in depressed inpatients. Pharmacopsychiatry 26:186-192.
16. Geretsegger C, Stuppaeck CH, Mair M, Platz T, Fartacek R, Heim M (1995) Multicentre double blind study of paroxetine and amitriptyline in elderly depressed patients. Psychopharmacology 119:277-281.
17. Ginestet D, Alby JM, Besancon G, Carrier G, Cordier B, Degiovanni A, Dufour H, Ferreri M, Leger L, Moron P, Pellet J, Perivier E, Singer L, Ulliac G (1989) Fluoxetine in endogenous depression melancholia versus clomipramine. Int Clin Psychopharmacol 4:37-40.
18. Guelfi JD, Dreyfus JF, Pichot P, GEPECP (1983) A double-blind controlled clinical trial comparing fluvoxamine with imipramine. Br J Clin Pharmacol 15:411S-417S.
19. Guy W, Wilson WH, Ban TA, King DL, Manov G, Fjetland IK (1984) Double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Psychopharmacol Bull 20:73-78.
20. Hamilton M (1960) A rating scale for depression. J Neurol, Neurosurg Psychiatry 23:56-63.
21. Hedges LV, Olkin I (1985) Statistical Methods for Meta-Analysis. Orlando: Academic Press Inc.
22. Kasper S, Voll G, Vieira A, Kick H (1990) Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression - results of a double-blind trial. Pharmacopsychiatry 23:135-142.
23. Klok CJ, Brouwer GJ, Van Praag HM, Doogan D (1981) Fluvoxamine and clomipramine in depressed patients: A double-blind clinical study. Acta Psychiatr Scand 64.1-11.
24. Lapierre YD, Browne M, Horn E, Oyewumi LK, Sarantidis D, Roberts N, Badoe K, Tessier P (1987) Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry 48: 65-68
25. Laursen LA, Mikkelsen PL, Rasmussen S, le Fevre Honore P (1985) Paroxetine in the treatment of depression - a randomized comparison with amitripryline. Acta Psychiatr Scand 71 249-255.
26. Lingjaerde O (1985) From clomipramine to mianserin: therapeutic relevance of interactions with serotonin uptake and storage, as studied in the blood platelet model. Acta Psychiatr Scand 320(Suppl.):10-19.
27. Manna V, Martucci N, Agnoli A (1989) Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders. Int Clin Psychopharmacol 4:81-88.
28. Moller H-J, Berzewski H, Eckmann F, Gonzalves N, Kissling W, Knorr W, Ressler P, Rudolf GAE, Steinmeyer EM, Magyar I, Szucs R, Szilard J (1993) Double-blind multicentre study of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiatry 26:75-78
29. Montgomery SA, Kasper S (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis. Int Clin Psychopharmacol 9(Suppl 4): 33-40.
30. Nathan RS, Perel JM, Pollock BG, Kupfer DJ (1990) The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. J Clin Psychiatr 51:367-372.
31. Nielsen OA, Mosing I, Petersen JS, Larsen T, Moller SE, Manniche PM, Skausig OB (1991) Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta Psychiatr Scand 84:233-241.
32. Ottevanger EA (1991) The efficacy of fluvoxamine in patients with severe depression. Br J Clin Res 2:125-132.
33. Ottevanger EA (1995) Fluvoxamine and clomipramine in depressed hospitalised patients: Results from a randomised, double-blind study. L'Encephale 21:317-321.
34. Pande AC, Sayler ME (1993) Fluoxetine - A clinical and research update: Severity of depression and response to fluoxetine. Int Clin Psychopharmacol 8:243-245.
35. Ross SB, Renyi AL (1975) Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol Toxicol 36:382-394.
36. Sangdee C, Franz DN (1979) Enhancement of central norepinephrine and 5-hydroxytryptamine transmission by tricyclic antidepressants. A comparison. Psychopharmacology 62:9-16.
37. Simon GE, VonKorff M, Heiligenstein H, Revicki DA, Grothaus MA, Katon W, Wagner EH (1996) Initial antidepressant choice in primary care: Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 275:1897-1902.
38. Staner L, Kerkhofs M, Detroux D, Leyman S, Linkowski P, Mendlewicz J (1995) Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind randomized trial in major depression. Sleep 18:470-477.
39. Stuppaeck CH, Geretsegger C, Whitworth AB, Schubert H, Platz T, Konig P, Hinterhuber H, Fleischhacker W (1994) A multicentre double-blind trial of paroxetine versus amitriptyline in depressed inpatients. J Clin Psychopharmacol 14:241-246.
40. Timmerman L, De Beurs P, Tan BK, Leijnse-Ybema H, Sanchez C, Hopfner Petersen HE, Cohen-Stuart MH (1987) A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients. Int Clin Psychopharmacol 2:239-253.